VolitionRx
In Brief This Week: T2 Biosystems; Aspira Women's Health; VolitionRx; ATCC; BARDA; Devyser
News items for the week of June 26, 2023.
VolitionRx Prices $16.5M Public Offering
The company plans to use the proceeds of the offering for R&D, working capital, and general corporate purposes, among other things.
In Brief This Week: Abbott, Thermo Fisher Scientific, Danaher, Oncocyte, Biocartis, More
News items for the week of Feb. 20, 2023.
VolitionRx Prices $7.5M Public Offering
Volition intends to use the proceeds for research and continued product development and clinical studies, among other things.
In Brief This Week: Thermo Fisher Scientific, Leica Biosystems, Genetron, SomaLogic, More
News items for the week of Nov. 7, 2022.
Jul 29, 2022
VolitionRx Prices $6M Public Offering
May 31, 2022
VolitionRx Gets CE Mark for NETosis Test
Feb 10, 2021
VolitionRx Prices $20M Public Offering
May 20, 2020
VolitionRx Prices $13.8M Stock Offering
Jul 10, 2019